Applied DNA To Present at 30th Annual Roth Capital Conference on March 13

Applied DNA To Present at 30 ^th Annual Roth Capital Conference on March 13

Applied DNA Sciences, Inc. (NASDAQ: APDN) today announced that Dr. James Hayward, president & CEO, is scheduled to present at the 30^th Annual ROTH Capital Markets Conference in Dana Point, CA on Tuesday, March 13 at 7:30 p.m. ET / 4:30 p.m. PT. Dr. Hayward will also hold one-on-one meetings with institutional investors and analysts at the conference.

A live webcast and replay of the presentation will be available on the company’s investor relations website at http://adnas.com/adnas_home/investors.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based CertainT^® platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature^®T and fiberTyping^®, targeted towards textiles and apparel, BackTrac^® and DNAnet^® and SmartDNA^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

For Applied DNA Sciences, Inc.
Investors:
Sanjay M. Hurry, 212-838-3777
LHA Investor Relations
shurry@lhai.com
or
Web: www.adnas.com | twitter: @APDN

View source version on businesswire.com: http://www.businesswire.com/news/home/20180228005049/en/